PMEDF / Predictmedix announces completion of 1,600-person clinical study for Safe Entry's medical device regulatory approval in Indonesia

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) told investors it has been invited to showcase its innovative impairment screening technology at the D-30 more_horizontal

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) said it has returned from a month-long international campaign during which it achieved numerous corporate more_horizontal

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) told investors its executive team is going on a strategic visit to India this weekend to engage with inst more_horizontal

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) said it is “poised to lead the charge in AI-driven healthcare solutions” after a strong start to 2023 more_horizontal

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) said its artificial intelligence (AI) product suite can now detect early signs of diabetes by analyzing s more_horizontal

Predictmedix AI Inc revealed it had surpassed 200,000 individual scans through its AI-powered Safe Entry Stations. The stations, equipped with advance more_horizontal

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) has announced significant progress in its efforts to introduce Safe Entry Stations (SES) into Indonesia' more_horizontal

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) said its fully owned Indian subsidiary, Predictmedix India Private Ltd, has engaged an Indian supplier fo more_horizontal